Ha Tay Pharmaceutical JSC (HNX:DHT)
Vietnam · Delayed Price · Currency is VND 65,700
-800 (-1.20%)
At close: Jun 5, 2026
Ha Tay Pharmaceutical JSC Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 4, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 5,950,714 | 6,340,200 | 7,822,325 | 1,893,826 | 1,027,245 | 1,188,329 | |
Market Cap Growth | -12.40% | -18.95% | 313.04% | 84.36% | -13.56% | 5.54% |
Enterprise Value | 6,077,970 | 6,536,629 | 7,994,725 | 2,176,376 | 1,106,314 | 1,060,741 |
Last Close Price | 65700.00 | 70000.00 | 86363.64 | 20336.49 | 12284.00 | 13536.16 |
PE Ratio | 101.84 | 118.16 | 108.99 | 22.27 | 10.79 | 17.49 |
PS Ratio | 2.48 | 2.64 | 3.75 | 0.95 | 0.56 | 0.74 |
PB Ratio | 5.36 | 5.71 | 7.40 | 1.78 | 1.29 | 1.58 |
P/TBV Ratio | 5.50 | 5.86 | 7.61 | 1.83 | 1.33 | 1.63 |
P/FCF Ratio | 33.63 | 35.83 | - | - | - | - |
P/OCF Ratio | 26.36 | 28.09 | 279.78 | 6.99 | - | - |
EV/Sales Ratio | 2.53 | 2.72 | 3.83 | 1.09 | 0.60 | 0.66 |
EV/EBITDA Ratio | 84.13 | 100.79 | 82.43 | 18.71 | 9.23 | 13.48 |
EV/EBIT Ratio | 126.36 | 160.56 | 104.49 | 21.94 | 10.80 | 17.09 |
EV/FCF Ratio | 34.35 | 36.94 | - | - | - | - |
Debt / Equity Ratio | 0.30 | 0.30 | 0.45 | 0.47 | 0.42 | 0.38 |
Debt / EBITDA Ratio | 5.14 | 5.14 | 4.85 | 4.33 | 2.81 | 3.68 |
Debt / FCF Ratio | 1.88 | 1.88 | - | - | - | - |
Net Debt / Equity Ratio | 0.09 | 0.09 | 0.27 | 0.11 | 0.23 | -0.18 |
Net Debt / EBITDA Ratio | 1.52 | 1.52 | 2.99 | 1.05 | 1.53 | -1.69 |
Net Debt / FCF Ratio | 0.56 | 0.56 | -2.52 | -1.27 | -0.64 | 1.59 |
Asset Turnover | 1.25 | 1.25 | 1.11 | 1.21 | 1.36 | 1.49 |
Inventory Turnover | 4.21 | 4.21 | 4.12 | 4.28 | 4.12 | 4.08 |
Quick Ratio | 0.47 | 0.47 | 0.40 | 0.81 | 0.47 | 1.18 |
Current Ratio | 1.22 | 1.22 | 1.21 | 1.69 | 1.80 | 2.10 |
Return on Equity (ROE) | 5.45% | 5.45% | 7.08% | 9.54% | 12.75% | 12.95% |
Return on Assets (ROA) | 1.32% | 1.32% | 2.54% | 3.75% | 4.73% | 3.60% |
Return on Invested Capital (ROIC) | 2.64% | 2.56% | 4.76% | 7.37% | 10.27% | 9.03% |
Return on Capital Employed (ROCE) | 3.40% | 3.40% | 6.60% | 8.00% | 11.30% | 8.20% |
Earnings Yield | 0.90% | 0.85% | 0.92% | 4.49% | 9.27% | 5.72% |
FCF Yield | 2.97% | 2.79% | -1.47% | -5.05% | -27.84% | -7.05% |
Dividend Yield | - | - | - | - | 2.64% | 2.40% |
Payout Ratio | - | - | 111.73% | - | 53.87% | 29.96% |
Buyback Yield / Dilution | 8.17% | 8.17% | -62.83% | 31.61% | -0.77% | 0.77% |
Total Shareholder Return | 8.17% | 8.17% | -62.83% | 31.61% | 1.87% | 3.17% |